MTOR and autosomal dominant polycystic kidney disease: These renal cysts responded to some drugs known to inhibit cyst formation in ADPKD, such as mammalian target of rapamycin (mTOR), indicating that these models can be used to screen drug compounds that prevent renal cyst formation [31] (Fig. 3e).